Moderna has announced that it has also initiated a vaccine approval process in Canada, the United Kingdom, Israel and Singapore.
–
The company also released the results of the third trial phase. In the third phase, which involved 30,000 participants, the vaccine was effective in 94.1% of cases.
–
Preliminary results showed that the Covid-19 vaccine developed by Moderna was 94.5% effective in clinical trials.
–
The company said that trials of the vaccine have so far not raised any serious concerns about the safety of the vaccine.
— .
